系统治疗与高级非小细胞肺癌成年人生存率的关联
Nikki M Carroll1, Jennifer Eisenstein2, Jared M Freml1
1Institute for Health Research, Kaiser Permanente Colorado, Central Support Services, Aurora, CO, USA.
Translational lung cancer research
|February 17, 2025
概括
新的全身疗法,包括免疫疗法和向治疗,显著改善了社区环境中高级非小细胞肺癌 (NSCLC) 患者的存活率,与单独的化疗相比. 一年生存率也从2012年到2020年大幅增加.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
- 公共卫生 公共卫生
背景情况:
- 先进的非小细胞肺癌 (NSCLC) 治疗格局随着新的全身疗法而迅速发展.
- 在社区环境中,这些新治疗方法对生存的影响的现实数据有限.
- 这项研究研究了在高级NSCLC患者中与不同系统疗法相关的生存结果,这些患者在专门癌症中心之外接受治疗.
研究的目的:
- 评估不同类型的全身疗法与晚期NSCLC患者的存活率之间的关联.
- 将免疫疗法和向治疗与传统化疗在社区环境中的生存结果进行比较.
- 分析随着时间的推移,高级NSCLC的一年生存概率的趋势.
主要方法:
- 在2012年3月至2020年12月期间诊断的新发IV期NSCLC患者的回顾性队列研究.
- 使用受限平均存活时间 (RMST) 在治疗开始后的12个月和60个月的生存分析.
- 结点回归用于评估一年生存概率的趋势.
主要成果:
- 接受免疫疗法+/-化疗或向疗法的患者与仅接受化疗的患者相比,存活时间更长.
- 向疗法与12个月生存率的1.6个月增加和60个月生存率的5.5个月增加相比,仅有化疗疗法.
- 晚期NSCLC患者的一年生存概率在2012年至2020年间显著增加,从30%增加到59%.
结论:
- 系统疗法,特别是向药物和免疫疗法,为社区环境中的高级NSCLC患者提供生存益处.
- 一年生存率的显著上升趋势凸显了治疗进步的积极影响.
- 需要进一步的研究来探索与这些疗法相关的潜在益处,不良事件和财务毒性.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:21Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K